Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
出版年份 2023 全文链接
标题
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2023-06-14
DOI
10.1093/jac/dkad143
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia
- (2022) Abhishek Maiti et al. CANCER JOURNAL
- Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association
- (2022) Jannik Stemler et al. Lancet Haematology
- Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML)
- (2022) Romain Sechaud et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
- (2022) Lisa Kriegl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
- (2021) Martin Hoenigl et al. LANCET INFECTIOUS DISEASES
- A novel highly bio‐available itraconazole formulation (SUBA®‐Itraconazole) for anti‐fungal prophylaxis in lung transplant recipients
- (2021) Timothy James Whitmore et al. Transplant Infectious Disease
- When azoles cannot be used: the clinical effectiveness of intermittent liposomal amphotericin prophylaxis in haematology patients
- (2021) R Batchelor et al. Open Forum Infectious Diseases
- Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions
- (2021) Will Garner et al. Journal of Fungi
- Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
- (2021) Annika Y. Classen et al. ANNALS OF HEMATOLOGY
- Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia
- (2021) Caitlin R. Rausch et al. CANCER
- Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole
- (2021) Malene Risum et al. Antibiotics-Basel
- Aspergillus terreus Species Complex
- (2021) Cornelia Lass-Flörl et al. CLINICAL MICROBIOLOGY REVIEWS
- Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients
- (2021) Julien Coussement et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer
- (2021) Carolin E.M. Jakob et al. EUROPEAN JOURNAL OF CANCER
- Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
- (2021) Pinkal M. Desai et al. JOURNAL OF CLINICAL ONCOLOGY
- Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib
- (2021) Muneerah M. Aleissa et al. LEUKEMIA RESEARCH
- Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
- (2021) Yael Bogler et al. MEDICAL MYCOLOGY
- Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
- (2021) Maria Daniela Bergamasco et al. Journal of Fungi
- The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
- (2021) Martin Hoenigl et al. DRUGS
- Harnessing the benefits of available targeted therapies in acute myeloid leukaemia
- (2021) Hagop Kantarjian et al. Lancet Haematology
- The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
- (2021) Andrzej Czyrski et al. Pharmaceutics
- A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT)
- (2020) Anat Stern et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study
- (2020) Melissa S. Copley et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
- (2020) Cristina López-Sánchez et al. Revista Espanola de Quimioterapia
- Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study
- (2020) Prithviraj Bose et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients
- (2020) Palash Samanta et al. CLINICAL INFECTIOUS DISEASES
- Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
- (2020) Ruth Van Daele et al. Expert Opinion on Drug Metabolism & Toxicology
- Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation
- (2020) A. Gómez-López CLINICAL MICROBIOLOGY AND INFECTION
- Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis
- (2020) Brunella Posteraro et al. MYCOSES
- Breakthrough Invasive Fungal Infections: Who is at risk?
- (2020) Jeffrey D. Jenks et al. MYCOSES
- Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta‐analysis
- (2020) Yee Shen Loo et al. ORAL DISEASES
- Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
- (2020) Maximilian Christopeit et al. ANNALS OF HEMATOLOGY
- Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial
- (2020) George R Thompson et al. CLINICAL INFECTIOUS DISEASES
- Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies
- (2020) Ghady Haidar et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients
- (2020) Jörg Janne Vehreschild et al. MEDICAL MYCOLOGY
- Attributable mortality of candidemia after introduction of echinocandins
- (2020) Florian B. Cornely et al. MYCOSES
- Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six‐year cohort analysis
- (2020) Sebastian M. Wingen‐Heimann et al. MYCOSES
- Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature
- (2020) Jonathan Youngs et al. Journal of Fungi
- Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent
- (2020) Lindsey Cass et al. Pharmacology Research & Perspectives
- Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study
- (2019) Makoto Iwasaki et al. BMC INFECTIOUS DISEASES
- Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients
- (2019) Lauren Fontana et al. CLINICAL INFECTIOUS DISEASES
- Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
- (2019) E Furfaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients
- (2019) Woo-Hyoung Kang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
- (2019) Anne‐Grete Märtson et al. MYCOSES
- Treatment by posaconazole tablets did not reduced variability of posaconazole trough concentrations compared to posaconazole suspension
- (2019) Elodie Gautier-Veyret et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study
- (2019) Ikuyo Tsutsumi et al. International Journal of Clinical Oncology
- Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies
- (2019) Blake Nield et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors associated with insufficient and potentially toxic voriconazole plasma concentrations: an observational study
- (2019) Xiaochen Wei et al. JOURNAL OF CHEMOTHERAPY
- Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
- (2019) Jorge E Cortes et al. LANCET ONCOLOGY
- Prospective CYP2C19 ‐Guided Voriconazole Prophylaxis in Neutropenic AML Patients Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations
- (2019) J. Kevin Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice
- (2019) Silke Schelenz et al. JOURNAL OF INFECTION
- Voriconazole prophylaxis in leukemic patients: A retrospective single-center study
- (2019) Vivian Bui et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Venetoclax Dosing in Combination with Antifungal Agents: Real World Experience in Patients with Acute Myeloid Leukemia
- (2019) Caitlin R. Rausch et al. BLOOD
- Invasive Mold Infections After Chimeric Antigen Receptor–Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis
- (2019) Ghady Haidar et al. CLINICAL INFECTIOUS DISEASES
- Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia
- (2019) Brian T. Fisher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis
- (2019) Achim Rothe et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinical Outcomes of the Oral Suspension versus Delayed-release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
- (2018) Jon P. Furuno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
- (2018) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis
- (2018) Lu Chen et al. BMC INFECTIOUS DISEASES
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study
- (2018) L. Tang et al. JOURNAL DE MYCOLOGIE MEDICALE
- Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study
- (2018) David J. Epstein et al. JOURNAL OF INFECTION
- Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
- (2018) Mar Tormo et al. MYCOSES
- Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study
- (2018) Ming-Yu Lien et al. PLoS One
- Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
- (2018) Sheng-Hsuan Chien et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome
- (2018) Kynlon Phillips et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Cost-effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities
- (2017) Juan F. Combariza et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
- (2017) Ray Hachem et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
- (2017) Philipp Koehler et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
- (2017) Julian Lindsay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors for subtherapeutic levels of posaconazole tablet
- (2017) Laura A Tang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
- (2017) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
- (2017) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations
- (2017) Katharine E. Stott et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
- (2017) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effectiveness of environmental control measures to decrease the risk of invasive aspergillosis in acute leukaemia patients during hospital building work
- (2017) J.F. Combariza et al. JOURNAL OF HOSPITAL INFECTION
- Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China
- (2017) Xiao-han Xu et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies
- (2017) Ka-Won Kang et al. LEUKEMIA RESEARCH
- Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients with Hematologic Malignancies
- (2017) Hyeon Jeong Suh et al. THERAPEUTIC DRUG MONITORING
- Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
- (2016) Andrew J. Ullmann et al. ANNALS OF HEMATOLOGY
- A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients
- (2016) L. M. Biehl et al. ANNALS OF ONCOLOGY
- Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels
- (2016) Jürgen Prattes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2016) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients
- (2016) Silvia Park et al. JOURNAL OF INFECTION
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia
- (2016) G. Venton et al. MEDECINE ET MALADIES INFECTIEUSES
- A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction
- (2016) Mehmet Özen et al. Turkish Journal of Hematology
- Failure to achieve therapeutic levels with high-dose posaconazole tablets potentially due to enhanced clearance
- (2016) Sam Maleki et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach
- (2015) Meinolf Karthaus et al. ANNALS OF HEMATOLOGY
- Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis
- (2015) Ying Jiao Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)
- (2015) M. Caira et al. HAEMATOLOGICA
- Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life
- (2015) Ga-Lai M. Chong et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Invasive Aspergillosis in Neutropenic Patients During Hospital Renovation: Effectiveness of Mechanical Preventive Measures in a Prospective Cohort of 438 Patients
- (2015) Michael Loschi et al. MYCOPATHOLOGIA
- Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)
- (2015) M. Caira et al. HAEMATOLOGICA
- Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2014) Daniela Tacke et al. ANNALS OF HEMATOLOGY
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases
- (2014) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease
- (2014) Huong Luu Tran et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
- (2011) David I. Marks et al. BRITISH JOURNAL OF HAEMATOLOGY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients
- (2009) G. Maschmeyer et al. ANNALS OF ONCOLOGY
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
- (2008) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
- (2008) Bart J. Rijnders et al. CLINICAL INFECTIOUS DISEASES
- Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2008) O. A. Cornely et al. HAEMATOLOGICA
- Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia
- (2008) Alison Gardner et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started